PPT-Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011

Patient back to baseline Vitals stable Sent to OSH where CT head shows old stroke Work up at outside including cardiac echo carotid US negative PMH as above plus two previous episodes of falling. CHS-University. Preceptor: Elaine Jones, RDN, LDN. Presenter: Chantal . Otelsberg. , M.S. .. November 20. th. , 2015 . . presentation OUTLINE. Introduction to Patient . Background of Underlying Medical Condition. Hosp. -based, hospital-based dialysis centers; . Indep. , independent dialysis providers; SDO, small dialysis organizations.. v. ol 2 Figure . 8.1 Dialysis units & patient counts, by unit affiliation, . 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 9.1 Trends in ESRD expenditures, 2004-2015. Data Source: USRDS ESRD Database; Reference Table K.1. Abbreviation: ESRD, end-stage renal disease. . Department of internal medicine #1 with cardiovascular pathology course. Topic 10: Secondary arterial Hypertension. . Secondary HTN. Clinical Clues:. Age - <20 or >50.. Severity – often Stage 2.. 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 3.1 Vascular access use at hemodialysis initiation, from the ESRD Medical Evidence form (CMS 2728), 2005-2015. Data Source: Special analyses, USRDS ESRD Database. ESRD patients initiating hemodialysis in 2005-2015. Abbreviations: AV, arteriovenous; CMS, Centers for Medicare & Medicaid; ESRD, end-stage renal disease. . Figure . 4.1 . Vascular access use at hemodialysis initiation, . from . the ESRD Medical Evidence form (CMS 2728), 2005-2013. Vol 2, ESRD, . Ch. 4. 2. 3. AV. fistula. AV graft. Catheter with maturing fistula. (bars; scale on right), and annual change (%) in the adjusted* incidence rate of ESRD . (lines; scale on left) in the U.S. population, 1996-2013. Vol 2, ESRD, Intro. 2. Data Source: Reference Table A.2(2) and special analyses, USRDS ESRD Database. *Adjusted for age, sex, and race.. CROWNWeb. for December 2014, restricted to patients as follows: Panel a: Dialysis patients initiating treatment for ESRD at least 1 year prior to December 1, 2014, and who were alive through December 31, 2014. and Young Adults. 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 7.1 (a) Incidence and, (b) December 31. st. point prevalence of ESRD among pediatric patients (aged 0–21 years), by modality, 1996-2015. 463 Chapter 7 : ESRD among Children, Adolescents, and Young Adults  The number of children and adolescents beginning end - stage renal disease ( ESRD ) care is steadily decreasing from a high Tx. , transplant.. Figure . 8.1 . Number of (a) incident and (b) December 31 point prevalent ESRD . pediatric . patients (aged 0–21 years), by modality, 1996-2013. Vol 2, ESRD, . Ch. 8. 2. Incident. DR CHAITHRA K. JR1 MEDICINE. HYPERTENSION IS ONE OF THE LEADING CAUSES OF GLOBAL BURDEN OF DISEASE. A Case . Presentation. LT . Mariela C Ventocilla, M.D. ., USN, Naval Hospital Jacksonville . LT Christopher . Gilbertson , D.O. . , USN, Naval Hospital Jacksonville. LCDR . Daniel Kuckel, M.D. ., USN, Naval Hospital Jacksonville. What effect does glycemic control with insulin have on these complications?. None. . Insulin does not improve mortality rates/neurological outcomes after stroke. Why do we care?. Stroke is the 5. th.